S163: EFFICACY OF JAK 1/2 INHIBITION IN MURINE IMMUNE BONE MARROW FAILURE

• E. Groarke,
• X. Feng,
• N. Aggarwal,
• A. L. Manley,
• Z. Wu,
• S. Gao,
• B. Patel,
• J. Chen,
• N. Young

Affiliations

E. Groarke

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

X. Feng

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

N. Aggarwal

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

A. L. Manley

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

Z. Wu

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

S. Gao

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

B. Patel

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

J. Chen

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America

N. Young

1 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, United States of America